Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAvacta Group Share News (AVCT)

Share Price Information for Avacta Group (AVCT)

Share Price is delayed by 15 minutes
Get Live Data
71.00    -5.00 (-6.67%)
Bid:
70.00
Ask:
72.00
Spread: 2.00 (2.857%)
Market Cap: £318.58m
AVCT Live PriceLast checked at - London Stock Exchange

Intraday Avacta Group Share Chart

Avacta Group News

LONDON BROKER RATINGS: AstraZeneca target raised; Antofagasta lowered
7 May 2024

LONDON BROKER RATINGS: AstraZeneca target raised; Antofagasta lowered

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Friday:

IN BRIEF: Avacta picks Christina Coughlin to replace long-serving CEO
1 May 2024

IN BRIEF: Avacta picks Christina Coughlin to replace long-serving CEO

Avacta Group PLC - Wetherby, West Yorkshire-based life sciences company developing cancer treatments and diagnostics - Promotes Christina Coughlin to ...

EARNINGS: Avacta sales jump; Poolbeg loss narrows; Digital 9 NAV down
30 Apr 2024

EARNINGS: Avacta sales jump; Poolbeg loss narrows; Digital 9 NAV down

(Alliance News) - The following is a round-up of earnings for London-listed companies, issued on Tuesday and not separately reported by Alliance News:

TRADING UPDATES: First Tin updates Tellerhauser estimates
22 Apr 2024

TRADING UPDATES: First Tin updates Tellerhauser estimates

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Monday and not separately reported by Alliance News:

Avacta reaches milestone in AVA6000 dose escalation
21 Mar 2024

Avacta reaches milestone in AVA6000 dose escalation

(Sharecast News) - Avacta Group announced a significant milestone in its phase 1a dose escalation study of AVA6000, its lead 'preCISION' drug, on Thur...

Avacta doses third patient in drug conjugate trial for tumour tissue
21 Mar 2024

Avacta doses third patient in drug conjugate trial for tumour tissue

(Alliance News) - Avacta Group PLC on Thursday said it dosed the third patient in the first cohort of its phase 1a dose escalation study for its lead ...

IN BRIEF: Avacta shareholders give AGM go-ahead to issue new shares
18 Mar 2024

IN BRIEF: Avacta shareholders give AGM go-ahead to issue new shares

Avacta Group PLC - Wetherby, England-based life sciences company developing oncology drugs and diagnostics - At annual general meeting on Monday, shar...